Groupe Pierre Fabre

Over 500 life-saving drugs used every day were born from the microbial world. And yet, 97% of this natural pharmacopoeia remains hidden, waiting to be discovered. At Generare, we believe these unexplored molecules hold the answers to diseases that still resist modern medicine.

We are building the only industrial-scale platform capable of uncovering this microbial treasure trove on a global scale. Our mission? To transform millions of years of nature’s trial-and-error into concrete therapeutic solutions for human and animal health, as well as the agriculture of tomorrow.

In 2025, our patented technology, combining synthetic biology and computational biology, has already led to the identification of over 200 new molecules derived from microbes, four times faster than the rest of the world combined.

At Takara Bio, our mission is to contribute to the development of revolutionary biotechnologies for the improvement of human health. Most known for our industry-leading enzymes and NGS solutions, we also offer a wide array of life science products and services in areas such as stem cell and gene therapies, and mRNA vaccine development.

Takara Bio Europe is a subsidiary of the Japanese company Takara Bio Inc., the company also has locations in the US and throughout Asia.

1ère enseigne de pharmaciens indépendants, créée en 2006 par Healthy Group, Aprium Pharmacie est aujourd’hui l’acteur n°1 de la pharmacie avec plus de 500 adhérents répartis sur l’ensemble du territoire national, soit 1.8md de chiffre d’affaires sous enseigne en 2024.

Ses adhérents sont unis autour d’un engagement simple : se concentrer sur l’écoute des patients et le conseil personnalisé pour veiller sur leur santé au quotidien.

Depuis sa création, les adhérents Aprium Pharmacie disposent d’une plateforme de services qui combine les avantages des réseaux traditionnels de pharmacie : la mutualisation des achats, pour optimiser la pertinence et la compétitivité de l’offre en officine, avec la mise à disposition de services à forte valeur ajoutée, tels que le marketing, les services digitaux, ou encore l’accompagnement des équipes officinales.

HelloBiome is an innovative B2B biotech startup leveraging the microbiome to revolutionize consumer health and beauty. We democratize access to microbiome data and implement AI models to develop targeted consumer solutions. We started with face and scalp, and have already expanded to body surface, intimate health, oral care, and nasal areas, using non-invasive sampling methods suitable for all ages.

We are now launching several predictive models for ingredient screening and diagnostics, building on our proprietary clinical datasets to create actionable solutions for partners worldwide.

Our technology is trusted by over 30 clients globally, including industry leaders like Unilever, L'Oreal and Cosmax.

Phagos is on a mission to create a cleaner, more sustainable future by using bacteria’s natural predator, the bacteriophage, to win the fight against antibiotic resistance and cure infectious diseases. We use breakthrough technologies in both the wet lab and dry lab to generate customized treatments for pathogenic diseases at an unprecedented speed.

L’entreprise MYCOPHYTO est une start-up innovante spécialisée dans l’isolement, la caractérisation et la production de Champignons Mycorhiziens Arbusculaires (CMA).

Elle propose des solutions microbiologiques personnalisées et accompagne les acteurs de l’agriculture pour :

• Dynamiser la biodiversité naturelle des sols

• Augmenter les rendements et la qualité des productions

• Réduire l’empreinte environnementale des cultures

• S’adapter au changement climatique

• Cultiver des produits sains respectueux de la santé des sols et des Hommes

MYCOPHYTO a pour ambition de devenir un acteur de référence pour proposer des solutions microbiologiques de biostimulation et réinventer l’agriculture de demain.